EGF Theramed Health Corp.
EGF Theramed Health Corp. TMED.CN Peers
See (TMED.CN) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Healthcare Information Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| TMED.CN | $0.13 | +100.00% | 1.51M | -6.50 | -$0.02 | N/A |
| KSI.TO | $6.75 | +2.27% | 637.18M | -225.00 | -$0.03 | N/A |
| VHI.TO | $10.20 | -0.10% | 550.72M | 255.00 | $0.04 | N/A |
| CARE.TO | $5.15 | +0.10% | 345.69M | -17.15 | -$0.30 | N/A |
| HS.CN | $0.53 | +3.92% | 29.01M | -3.31 | -$0.16 | N/A |
| TRUE.CN | $0.47 | +2.17% | 27.26M | -2.76 | -$0.17 | N/A |
| UDOC.CN | $0.27 | -11.67% | 20.22M | -3.31 | -$0.08 | N/A |
| AIML.CN | $0.11 | -8.33% | 19.07M | -1.83 | -$0.06 | N/A |
| RYAH.CN | $0.03 | N/A | 11.20M | -0.15 | -$0.17 | N/A |
| TELE.CN | $0.09 | N/A | 7.59M | -0.13 | -$0.69 | N/A |
Stock Comparison
TMED.CN vs KSI.TO Comparison
TMED.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMED.CN stands at 1.51M. In comparison, KSI.TO has a market cap of 637.18M. Regarding current trading prices, TMED.CN is priced at $0.13, while KSI.TO trades at $6.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMED.CN currently has a P/E ratio of -6.50, whereas KSI.TO's P/E ratio is -225.00. In terms of profitability, TMED.CN's ROE is +0.29%, compared to KSI.TO's ROE of -0.05%. Regarding short-term risk, TMED.CN is less volatile compared to KSI.TO. This indicates potentially lower risk in terms of short-term price fluctuations for TMED.CN.
TMED.CN vs VHI.TO Comparison
TMED.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMED.CN stands at 1.51M. In comparison, VHI.TO has a market cap of 550.72M. Regarding current trading prices, TMED.CN is priced at $0.13, while VHI.TO trades at $10.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMED.CN currently has a P/E ratio of -6.50, whereas VHI.TO's P/E ratio is 255.00. In terms of profitability, TMED.CN's ROE is +0.29%, compared to VHI.TO's ROE of +0.02%. Regarding short-term risk, TMED.CN is less volatile compared to VHI.TO. This indicates potentially lower risk in terms of short-term price fluctuations for TMED.CN.
TMED.CN vs CARE.TO Comparison
TMED.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMED.CN stands at 1.51M. In comparison, CARE.TO has a market cap of 345.69M. Regarding current trading prices, TMED.CN is priced at $0.13, while CARE.TO trades at $5.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMED.CN currently has a P/E ratio of -6.50, whereas CARE.TO's P/E ratio is -17.15. In terms of profitability, TMED.CN's ROE is +0.29%, compared to CARE.TO's ROE of -0.23%. Regarding short-term risk, TMED.CN is less volatile compared to CARE.TO. This indicates potentially lower risk in terms of short-term price fluctuations for TMED.CN.
TMED.CN vs HS.CN Comparison
TMED.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMED.CN stands at 1.51M. In comparison, HS.CN has a market cap of 29.01M. Regarding current trading prices, TMED.CN is priced at $0.13, while HS.CN trades at $0.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMED.CN currently has a P/E ratio of -6.50, whereas HS.CN's P/E ratio is -3.31. In terms of profitability, TMED.CN's ROE is +0.29%, compared to HS.CN's ROE of -1.34%. Regarding short-term risk, TMED.CN is less volatile compared to HS.CN. This indicates potentially lower risk in terms of short-term price fluctuations for TMED.CN.
TMED.CN vs TRUE.CN Comparison
TMED.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMED.CN stands at 1.51M. In comparison, TRUE.CN has a market cap of 27.26M. Regarding current trading prices, TMED.CN is priced at $0.13, while TRUE.CN trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMED.CN currently has a P/E ratio of -6.50, whereas TRUE.CN's P/E ratio is -2.76. In terms of profitability, TMED.CN's ROE is +0.29%, compared to TRUE.CN's ROE of -11.21%. Regarding short-term risk, TMED.CN is less volatile compared to TRUE.CN. This indicates potentially lower risk in terms of short-term price fluctuations for TMED.CN.
TMED.CN vs UDOC.CN Comparison
TMED.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMED.CN stands at 1.51M. In comparison, UDOC.CN has a market cap of 20.22M. Regarding current trading prices, TMED.CN is priced at $0.13, while UDOC.CN trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMED.CN currently has a P/E ratio of -6.50, whereas UDOC.CN's P/E ratio is -3.31. In terms of profitability, TMED.CN's ROE is +0.29%, compared to UDOC.CN's ROE of +6.57%. Regarding short-term risk, TMED.CN and UDOC.CN have similar daily volatility (0.00).
TMED.CN vs AIML.CN Comparison
TMED.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMED.CN stands at 1.51M. In comparison, AIML.CN has a market cap of 19.07M. Regarding current trading prices, TMED.CN is priced at $0.13, while AIML.CN trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMED.CN currently has a P/E ratio of -6.50, whereas AIML.CN's P/E ratio is -1.83. In terms of profitability, TMED.CN's ROE is +0.29%, compared to AIML.CN's ROE of -11.81%. Regarding short-term risk, TMED.CN is less volatile compared to AIML.CN. This indicates potentially lower risk in terms of short-term price fluctuations for TMED.CN.
TMED.CN vs RYAH.CN Comparison
TMED.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMED.CN stands at 1.51M. In comparison, RYAH.CN has a market cap of 11.20M. Regarding current trading prices, TMED.CN is priced at $0.13, while RYAH.CN trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMED.CN currently has a P/E ratio of -6.50, whereas RYAH.CN's P/E ratio is -0.15. In terms of profitability, TMED.CN's ROE is +0.29%, compared to RYAH.CN's ROE of +14.95%. Regarding short-term risk, TMED.CN and RYAH.CN have similar daily volatility (0.00).
TMED.CN vs TELE.CN Comparison
TMED.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMED.CN stands at 1.51M. In comparison, TELE.CN has a market cap of 7.59M. Regarding current trading prices, TMED.CN is priced at $0.13, while TELE.CN trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMED.CN currently has a P/E ratio of -6.50, whereas TELE.CN's P/E ratio is -0.13. In terms of profitability, TMED.CN's ROE is +0.29%, compared to TELE.CN's ROE of +0.00%. Regarding short-term risk, TMED.CN and TELE.CN have similar daily volatility (0.00).
TMED.CN vs LYNX.CN Comparison
TMED.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMED.CN stands at 1.51M. In comparison, LYNX.CN has a market cap of 6.43M. Regarding current trading prices, TMED.CN is priced at $0.13, while LYNX.CN trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMED.CN currently has a P/E ratio of -6.50, whereas LYNX.CN's P/E ratio is -0.29. In terms of profitability, TMED.CN's ROE is +0.29%, compared to LYNX.CN's ROE of +0.00%. Regarding short-term risk, TMED.CN and LYNX.CN have similar daily volatility (0.00).
TMED.CN vs DMED.CN Comparison
TMED.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMED.CN stands at 1.51M. In comparison, DMED.CN has a market cap of 3.20M. Regarding current trading prices, TMED.CN is priced at $0.13, while DMED.CN trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMED.CN currently has a P/E ratio of -6.50, whereas DMED.CN's P/E ratio is -4.00. In terms of profitability, TMED.CN's ROE is +0.29%, compared to DMED.CN's ROE of +5.62%. Regarding short-term risk, TMED.CN is less volatile compared to DMED.CN. This indicates potentially lower risk in terms of short-term price fluctuations for TMED.CN.
TMED.CN vs LITE.CN Comparison
TMED.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMED.CN stands at 1.51M. In comparison, LITE.CN has a market cap of 2.04M. Regarding current trading prices, TMED.CN is priced at $0.13, while LITE.CN trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMED.CN currently has a P/E ratio of -6.50, whereas LITE.CN's P/E ratio is -0.50. In terms of profitability, TMED.CN's ROE is +0.29%, compared to LITE.CN's ROE of -6.63%. Regarding short-term risk, TMED.CN and LITE.CN have similar daily volatility (0.00).
TMED.CN vs CBP.CN Comparison
TMED.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMED.CN stands at 1.51M. In comparison, CBP.CN has a market cap of 1.69M. Regarding current trading prices, TMED.CN is priced at $0.13, while CBP.CN trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMED.CN currently has a P/E ratio of -6.50, whereas CBP.CN's P/E ratio is -1.00. In terms of profitability, TMED.CN's ROE is +0.29%, compared to CBP.CN's ROE of +0.08%. Regarding short-term risk, TMED.CN and CBP.CN have similar daily volatility (0.00).
TMED.CN vs NARA.CN Comparison
TMED.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMED.CN stands at 1.51M. In comparison, NARA.CN has a market cap of 1.18M. Regarding current trading prices, TMED.CN is priced at $0.13, while NARA.CN trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMED.CN currently has a P/E ratio of -6.50, whereas NARA.CN's P/E ratio is -0.02. In terms of profitability, TMED.CN's ROE is +0.29%, compared to NARA.CN's ROE of +1.85%. Regarding short-term risk, TMED.CN and NARA.CN have similar daily volatility (0.00).
TMED.CN vs CGN.CN Comparison
TMED.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMED.CN stands at 1.51M. In comparison, CGN.CN has a market cap of 895886.00. Regarding current trading prices, TMED.CN is priced at $0.13, while CGN.CN trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMED.CN currently has a P/E ratio of -6.50, whereas CGN.CN's P/E ratio is -0.13. In terms of profitability, TMED.CN's ROE is +0.29%, compared to CGN.CN's ROE of +0.96%. Regarding short-term risk, TMED.CN and CGN.CN have similar daily volatility (0.00).
TMED.CN vs NDAT.CN Comparison
TMED.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMED.CN stands at 1.51M. In comparison, NDAT.CN has a market cap of 826548.00. Regarding current trading prices, TMED.CN is priced at $0.13, while NDAT.CN trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMED.CN currently has a P/E ratio of -6.50, whereas NDAT.CN's P/E ratio is -1.00. In terms of profitability, TMED.CN's ROE is +0.29%, compared to NDAT.CN's ROE of -0.62%. Regarding short-term risk, TMED.CN and NDAT.CN have similar daily volatility (0.00).
TMED.CN vs KETA.CN Comparison
TMED.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMED.CN stands at 1.51M. In comparison, KETA.CN has a market cap of 266327.00. Regarding current trading prices, TMED.CN is priced at $0.13, while KETA.CN trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMED.CN currently has a P/E ratio of -6.50, whereas KETA.CN's P/E ratio is -1.00. In terms of profitability, TMED.CN's ROE is +0.29%, compared to KETA.CN's ROE of +0.33%. Regarding short-term risk, TMED.CN and KETA.CN have similar daily volatility (0.00).